Rilotumumab
WikiDoc Resources for Rilotumumab |
Articles |
---|
Most recent articles on Rilotumumab Most cited articles on Rilotumumab |
Media |
Powerpoint slides on Rilotumumab |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Rilotumumab at Clinical Trials.gov Clinical Trials on Rilotumumab at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Rilotumumab
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Rilotumumab Discussion groups on Rilotumumab Patient Handouts on Rilotumumab Directions to Hospitals Treating Rilotumumab Risk calculators and risk factors for Rilotumumab
|
Healthcare Provider Resources |
Causes & Risk Factors for Rilotumumab |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Rilotumumab is a human monoclonal antibody and which it is used to treat cancer.
Template:Humanmonoclonals Template:SIB Template:WH Template:WS